Breast Cancer Research

official impact factor 5.79

Open Access Highly Access Research article

A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors

Dana Inbar-Rozensal1, Asher Castiel2, Leonid Visochek1, David Castel1, Françoise Dantzer3, Shai Izraeli2 and Malka Cohen-Armon1*

Author Affiliations

1 The Neufeld Cardiac Research Institute and Dept. of Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel

2 Cancer Research Institute, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel

3 Laboratory of Molecular and Structural Biology, Ecole Superieure de Biotechnologie de Strasbourg, F-67400, Illkrich-Graffenstaden, France

For all author emails, please log on.

Breast Cancer Research 2009, 11:R78 doi:10.1186/bcr2445


See related editorial by Frizzell and Kraus, http://breast-cancer-research.com/content/11/6/111

Published: 9 November 2009

Additional files

Additional file 1:

The following additional data are available with the online version of this article: A documented experiment, testing PJ-34 treatment in nude mice injected with MDA231 breast cancer cells (Additional data file 1).

Format: PDF Size: 1015KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data